The CO2-SFE crude lipid extract and the free fatty acid extract from Perna canaliculus have anti-inflammatory effects on adjuvant-induced arthritis in rats

Billingham, 1983, Models of arthritis and the search for anti-arthritic drugs, Pharmacol. Ther., 21, 389, 10.1016/0163-7258(83)90062-1 Celotti, 2001, Anti-inflammatory drugs: new multitarget compounds to face an old problem: the dual inhibition concept, Pharmacol. Res., 43, 429, 10.1006/phrs.2000.0784 Charlier, 2003, Dual inhibition of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) as a new strategy to provide safer non-steroidal anti-inflammatory drugs, Eur. J. Med. Chem., 38, 645, 10.1016/S0223-5234(03)00115-6 Cho, 2003, Tight-binding inhibition by α-naphthoflavone of human cytochrome P450 1A2, Biochim. Biophys. Acta, 1648, 195, 10.1016/S1570-9639(03)00148-1 Claria, 2005, Pharmacological intervention of cyclooxygenase-2 and 5-lipoxygenase pathways. Impact on inflammation and cancer, Curr. Pharm. Des., 11, 3431, 10.2174/138161205774370753 Fowler, 1996, Organelles as tools in toxicology, 1201 Freneaux, 1990, Steroselective and nonstereoselective effects of ibuprofen enantiomers on mitochondrial beta-oxidation of fatty acids, J. Pharmocol. Exp. Ther., 255, 529 Gil, 2002, Polyunsaturated fatty acids and inflammatory diseases, Biomed. Pharmacother., 56, 388, 10.1016/S0753-3322(02)00256-1 Ivens, 1993, Subchronic toxicity of 2, 3, 7, 8-tetrabromodibenzo-p-dioxin in rats, Toxicology, 83, 181, 10.1016/0300-483X(93)90101-W Jain, 2007, The biology and chemistry of hyperlipidemia, Bioorg. Med. Chem., 15, 4674, 10.1016/j.bmc.2007.04.031 Jala, 2004, Leukotrienes and athersclerosis: new roles for old mediators, Trends Immunol., 25, 315, 10.1016/j.it.2004.04.003 Lake, 1987, Preparation and characterisation of microsomal fractions for studies on xenobiotic metabolism, 183 Lee, 2001, Rheumatoid arthritis, Lancet, 358, 903, 10.1016/S0140-6736(01)06075-5 Markwell, 1978, A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples, Anal. Biochem., 87, 206, 10.1016/0003-2697(78)90586-9 McColl, 1987, Effect of dietary polyunsaturated fatty acid (PUFA) supplementation on adjuvant induced polyarthritis in rats, J. Rheumatol., 14, 197 McGarry, 1978, Carnitine palmitoyltransferase I. The site of inhibition of hepatic fatty acid oxidation by malonyl-CoA, J. Biol. Chem., 253, 4128, 10.1016/S0021-9258(17)34693-8 McPhee, 2001, The marine oil Lyprinol®, is a substrate for the 5-lipoxygenase enzyme in porcine neutrophils, Proc. Aust. Soc. Clin. Exp. Pharmacol. Toxicol., 9, 95 McPhee, 2007, Anti-cyclooxygenase effects of lipid extracts from the New Zealand green-lipped mussel, Perna canaliculus, Comp. Biochem. Physiol. B, 146, 346, 10.1016/j.cbpb.2006.11.001 Rainsford, 1982, Adjuvant polyarthritis in rats: is this a satisfactory model for screening anti-arthritic drugs?, Agents Actions, 12, 452, 10.1007/BF01965926 Schosinsky, 1974, Measurement of ceruloplasmin from its oxidase activity in serum by use of o-dianisidine dihydrochloride, Clin. Chem., 20, 1556, 10.1093/clinchem/20.12.1556 Stamp, 2005, Diet and rheumatoid arthritis: a review of the literature, Semin. Arthritis Rheum., 35, 77, 10.1016/j.semarthrit.2005.05.001 Tagliati, 1999, Pharmacokinetic profile and adverse gastric effect of zinc-piroxicam in rats, Gen. Pharmacol., 33, 67, 10.1016/S0306-3623(98)00267-5 Travlos, 1996, Frequency and relationships of clinical chemistry and liver and kidney histopathology findings in 13-week toxicity studies in rats, Toxicology, 107, 17, 10.1016/0300-483X(95)03197-N Treschow, 2007, Novel anti-inflammatory ω-3 PUFAs from the New Zealand green-lipped mussel, Perna canaliculus, Comp. Biochem. Physiol. B, 147, 645, 10.1016/j.cbpb.2007.04.004 Walz, 1971, Adjuvant-induced arthritis in rats. II. Drug effects on physiologic, biochemical and immunologic parameters, J. Pharmacol. Exp. Ther., 178, 223 Whitehouse, 1973, Impaired drug metabolism in rats with adjuvant-induced arthritis: a brief review, Drug Metab. Dispos., 1, 251 Whitehouse, 1997, Anti-inflammatory activity of a lipid fraction (Lyprinol) from the NZ green-lipped mussel, Inflammopharmacology, 5, 237, 10.1007/s10787-997-0002-0